Erythema in diseases classified elsewhere

L12_ERYTHINOTH

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 L54*
  • Cause of death: ICD-10 L54*

2 out of 7 registries used, show all original rules.

74

4. Check minimum number of events

None

74

5. Include endpoints

None

74

6. Filter based on genotype QC (FinnGen only)

74

Control definitions (FinnGen only)

Control exclude
L12_URTICARIAERYTHEMA

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 461 302 158
Only index persons 439 286 153
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.00
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 56.68 58.12 53.91
Only index persons 56.26 57.79 53.42

-FinnGen-

Key figures

All Female Male
Number of individuals 74 49 25
Unadjusted period prevalence (%) 0.01 0.02 0.01
Median age at first event (years) 54.10 51.01 60.16

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
68
Matched controls
681
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L548, A692
ICD-10 Finland
NA
+∞
43.5
37
*
A69.2
ICD-10 Finland
Lyme disease
27.0
20.1
28
17
L54.8
ICD-10 Finland
Erythema in other diseases classified elsewhere
+∞
17.4
16
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
7.1
8.6
22
43
L54.0*I00
ICD-10 Finland
Erythema marginatum in acute rheumatic fever
+∞
8.5
8
*

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40761535) Cells panel - Urine sediment
21
62
4.33
6.75
5.2
2.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
66
487
4.28
4.91
5.9
4.3
mm/h
11.1
12.0
0.27
60
443
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
25
4.99
4.74
1.2
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
74
629
+∞
4.69
18.1
13.5
mg/l
17.6
21.1
0.59
63
494
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
20
79
3.10
4.05
11.1
7.9
—
—
—
0
0
(3020891) Body temperature
10
27
4.13
3.48
7.6
5.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
30
166
2.36
3.06
8.6
6.9
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
9
22
4.50
2.99
2.7
1.4
g/l
1.1
1.2
—
9
22
(3011397) Hemoglobin [Presence] in Urine by Test strip
26
137
2.38
2.94
7.0
3.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
28
160
2.21
2.58
3.1
2.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
46
321
2.14
2.53
8.8
5.5
e9/l
0.6
0.6
0.41
41
285
(40768443) Skin Pathology biopsy report
8
22
3.95
2.44
1.4
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
17
83
2.36
2.23
3.6
2.0
s
31.6
28.9
0.53
17
83
(3000991) Gas panel - Venous blood
11
43
2.83
2.21
4.6
6.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
35
235
1.93
2.00
6.3
4.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
42
300
1.93
1.99
5.9
3.9
estimate
0.0
0.0
—
5
51
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
11
4.79
1.97
1.6
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
42
301
1.91
1.96
7.3
5.5
estimate
0.0
0.0
—
5
50
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
62
511
2.32
1.92
10.1
7.1
u/l
76.1
77.8
0.18
55
474
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
68
594
2.78
1.92
4.7
5.1
mu/l
2.0
1.9
0.26
54
541
(3036481) Cortisol [Moles/volume] in Serum or Plasma
14
67
2.34
1.91
2.5
2.0
nmol/l
366.6
379.1
0.10
14
62
(3030467) Casts [#/volume] in Urine by Automated count
27
170
1.93
1.84
3.6
3.2
e6/l
0.2
0.3
0.60
21
129
(3029937) Albumin [Presence] in Urine by Test strip
25
158
1.88
1.66
6.8
3.8
estimate
0.0
0.0
—
5
51
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
20
118
1.95
1.62
1.2
1.3
iu/ml
12.8
55.3
—
6
40
(3000494) Fungus identified in Specimen by Culture
14
72
2.16
1.62
1.1
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
32
222
1.78
1.57
3.9
3.4
e6/l
16.7
53.5
0.82
25
158
(3002582) Erythrocytes [#/volume] in Urine
28
187
1.80
1.56
3.9
3.1
e6/l
10.7
46.3
1.13
23
147
(3031040) Bacteria [#/volume] in Urine by Automated count
51
407
1.81
1.53
5.6
3.9
—
36.6
—
0
5
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
20
121
1.89
1.50
1.3
1.2
u/ml
14.4
10.7
—
7
51
(3044640) Blood type and Crossmatch panel - Blood
27
180
1.79
1.50
2.6
2.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
12
60
2.19
1.48
1.9
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
12
60
2.19
1.48
1.7
1.6
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
9
40
2.42
1.46
2.6
3.2
%
0.7
0.7
—
9
40
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
16
3.27
1.46
1.6
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
9
41
2.36
1.43
7.9
4.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
29
201
1.73
1.40
8.1
4.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
38
284
1.69
1.40
4.8
3.7
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
9
42
2.30
1.39
2.6
3.1
%
1.3
1.2
—
9
42
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
43
2.24
1.36
3.3
2.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
29
203
1.70
1.34
3.7
3.2
mmol/l
2.4
2.4
0.21
24
177
(3045414) Leukocytes [Presence] in Urine
6
24
2.63
1.33
3.5
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
34
250
1.67
1.31
5.2
3.7
ng/l
20.0
34.0
0.80
29
171
(3032080) INR in Blood by Coagulation assay
34
250
1.67
1.31
12.5
7.4
inr
1.3
1.1
—
7
76
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
19
2.74
1.23
1.0
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
8
38
2.24
1.23
1.6
1.4
—
—
—
0
0
(3012544) pH of Venous blood
12
65
2.01
1.22
2.3
3.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
20
130
1.74
1.19
3.1
2.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
15
89
1.86
1.18
2.2
1.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
20
2.60
1.17
1.0
1.3
—
3.7
—
0
5
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
20
2.60
1.17
1.0
1.3
—
1.9
—
0
6
(3023368) Bacteria identified in Blood by Culture
24
165
1.67
1.17
3.2
4.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
13
74
1.92
1.15
1.6
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
26
184
1.64
1.13
4.3
3.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
58
505
1.69
1.02
4.4
4.2
pmol/l
15.2
14.8
0.35
46
457
(46235355) HIV 1 and 2 tests - Meaningful Use set
14
86
1.77
0.99
1.2
1.5
—
—
—
0
0
(1002224) Polysomnography panel
0
31
0.00
0.99
0.0
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
28
2.24
0.94
8.8
6.6
mmol/l
24.4
25.2
—
6
28
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
11
64
1.84
0.92
2.2
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
14
89
1.71
0.89
3.9
4.4
%
28.9
33.1
—
9
54
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
106
0.53
0.80
1.5
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
63
572
1.68
0.80
15.3
14.5
%
37.6
39.7
0.49
37
400
(3037467) Urinalysis macro (dipstick) panel - Urine
49
422
1.48
0.79
6.3
4.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
24
180
1.49
0.79
4.1
2.9
ng/l
845.4
884.2
0.04
18
154
(40768804) Tissue Pathology biopsy report
32
255
1.45
0.78
1.7
2.0
—
—
—
0
0
(4034850)
5
26
1.99
0.72
19.0
13.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
21
156
1.48
0.72
7.7
5.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
14
95
1.58
0.70
2.8
2.7
mmol/l
0.8
0.8
0.69
14
88
(1761868) Lipid panel - Serum or Plasma
19
250
0.68
0.70
1.9
3.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
5
30
1.71
0.62
1.0
1.8
u/l
44.2
36.1
—
5
24
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
30
1.71
0.62
1.4
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
20
0.00
0.61
0.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
21
0.00
0.61
0.0
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
10
65
1.62
0.59
1.7
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
15
108
1.49
0.59
2.3
1.7
nmol/l
2377.7
1182.5
—
9
86
(3042936) Bacteria identified in Isolate by Culture
11
74
1.57
0.57
2.7
2.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
37
1.68
0.57
5.7
5.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
35
296
1.35
0.56
8.8
9.7
e9/l
0.0
0.0
0.50
28
250
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
65
614
1.48
0.48
7.3
6.0
mmol/mol
41.8
40.4
0.44
56
572
(3022621) pH of Urine by Test strip
7
48
1.51
0.48
5.7
2.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
10
70
1.50
0.44
2.4
3.1
umol/l
6.1
8.2
—
10
65
(3019225) pH of Specimen
8
59
1.40
0.42
9.0
3.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
20
162
1.32
0.41
1.4
1.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
46.9
—
0
18
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
6
41
1.50
0.37
1.2
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
41
1.50
0.37
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
12
91
1.38
0.36
2.3
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
6
43
1.43
0.36
2.3
3.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
23
194
1.27
0.35
3.8
3.1
mg/l
17.8
52.8
1.39
16
135
(3002256) Pathology report gross observation
10
74
1.41
0.34
1.3
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
67
642
1.46
0.33
5.7
4.7
mmol/l
4.9
4.7
0.75
61
589
(3013512) EKG study
24
207
1.24
0.30
3.8
4.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
12
94
1.33
0.30
4.8
2.9
e6/l
1.5
4.0
—
7
56
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
21
181
1.22
0.26
4.9
5.1
ug/l
3.8
1.7
1.00
16
158
(3022145) Colonoscopy Study observation
6
81
0.72
0.25
1.3
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
13
156
0.80
0.24
1.5
1.6
nmol/l
33.1
20.8
0.81
13
133
(3019832) Treponema pallidum Ab [Presence] in Serum
5
37
1.38
0.24
1.2
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
38
1.34
0.24
1.2
1.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
23
203
1.19
0.23
3.6
2.9
mmol/l
7.3
7.7
0.12
17
175
(3028026) IgM [Mass/volume] in Serum or Plasma
5
41
1.24
0.22
1.4
1.4
g/l
1.5
1.0
—
5
35
(3025130) Human papilloma virus identified in Specimen
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
10
0.00
0.21
0.0
4.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
3.5
—
15.8
—
0
12
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
64
618
1.26
0.21
5.2
4.1
mmol/l
1.4
1.3
0.97
58
563
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
39
364
1.15
0.19
2.8
2.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
7
58
1.23
0.19
1.9
2.2
g/l
0.3
0.2
—
7
52
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
8
67
1.22
0.17
1.4
4.1
ug/l
2.4
7.3
—
8
56
(3041096) Erythrocytes [Presence] in Urine by Automated
19
169
1.17
0.17
3.2
4.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
23
209
1.15
0.15
4.1
3.9
mg/mmol
11.1
7.8
0.14
15
139
(3004789) Transferrin [Mass/volume] in Serum or Plasma
11
97
1.16
0.09
2.5
2.4
g/l
2.3
2.4
0.12
11
86
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
27
254
1.10
0.09
1.6
2.0
pmol/l
90.3
98.4
0.45
12
131
(3044889) 12 lead EKG panel
44
456
0.91
0.09
4.6
3.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
54
1.12
0.09
1.5
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
66
1.07
0.08
2.3
3.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
8
75
1.07
0.08
1.1
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
67
657
1.21
0.07
6.4
5.2
mmol/l
3.0
2.8
1.09
59
601
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
65
640
1.13
0.07
5.9
4.7
mmol/l
1.5
1.5
0.02
58
586
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
20
193
1.05
0.01
1.5
1.7
mmol/l
1.6
1.3
0.64
15
159
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
14
137
1.03
0.00
3.3
4.4
%
18.0
20.9
—
8
65
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
15
146
1.03
0.00
1.3
1.2
u/ml
0.5
2.0
—
6
48
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
60
1.00
0.00
1.5
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
6
60
1.00
0.00
8.0
2.8
e9/l
115.3
71.6
—
6
49
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4268621)
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4035726)
5
56
0.89
0.00
1.4
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.0
—
5.7
—
0
6
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
15.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
19.2
—
921.6
—
0
5
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
88.8
—
0
8
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
0.9
—
0
7
(3023511) Choriogonadotropin [Units/volume] in Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
6.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
25.4
—
1306.6
—
0
5
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
1.3
—
0
6
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(4146454)
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
33.4
—
0
5

Mortality – FinRegistry

Association

Association between endpoint L12_ERYTHINOTH and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_ERYTHINOTH.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: L12_ERYTHINOTH – Erythema in diseases classified elsewhere

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data